HHL-U:CA:TSX-Harvest Healthcare Leaders Income ETF (USD)

ETF | Others |

Last Closing

CAD 9.47

Change

0.00 (0.00)%

Market Cap

N/A

Volume

1.43K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-08-28 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

N/A

CAD 6.19B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

+0.01 (+0.02%)

CAD 5.29B
PHYS-U:CA Sprott Physical Gold Trust

+0.22 (+1.11%)

CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

+0.19 (+0.54%)

CAD 4.54B
XEQT:CA iShares Core Equity Portfolio

+0.17 (+0.54%)

CAD 4.46B
HXT-U:CA Horizons S&P/TSX 60 Index ETF

N/A

CAD 3.92B
CEF-U:CA Sprott Physical Gold and Silve..

+0.59 (+2.51%)

CAD 3.78B
PSLV-U:CA Sprott Physical Silver Trust

+0.41 (+4.12%)

CAD 3.29B
NSCB:CA NBI Sustainable Canadian Bond ..

+0.02 (+0.09%)

CAD 2.78B
NUBF:CA NBI Unconstrained Fixed Income..

-0.10 (-0.46%)

CAD 2.52B

ETFs Containing HHL-U:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 11.54% 66% D+ 60% D-
Dividend Return 1.39% 76% C+ 41% F
Total Return 12.94% 70% C- 60% D-
Trailing 12 Months  
Capital Gain 10.76% 49% F 49% F
Dividend Return 1.38% 69% C- 29% F
Total Return 12.14% 50% F 47% F
Trailing 5 Years  
Capital Gain 25.76% 48% F 56% F
Dividend Return 3.12% 76% C+ 10% F
Total Return 28.88% 51% F 51% F
Average Annual (5 Year Horizon)  
Capital Gain 2.98% 61% D- 50% F
Dividend Return 3.35% 63% D 46% F
Total Return 0.37% 88% B+ 26% F
Risk Return Profile  
Volatility (Standard Deviation) 6.91% 58% F 80% B-
Risk Adjusted Return 48.47% 73% C 68% D+
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike